OxyContin’s makers delayed the reckoning for their role in the opioid crisis by funding think tanks, placing friendly experts on leading outlets, and deterring or challenging negative coverage.
[link removed]
The Big Story
Tue. Nov 19, 2019
[link removed]
Inside Purdue Pharma’s Media Playbook: How It Planted the Opioid “Anti-Story”
[link removed]
OxyContin’s makers delayed the reckoning for their role in the opioid crisis by funding think tanks, placing friendly experts on leading outlets, and deterring or challenging negative coverage.
by David Armstrong
View Story
[link removed]
More From This Investigation
[link removed]
Data Touted by OxyContin Maker to Fight Lawsuits Doesn’t Tell the Whole Story
[link removed]
Downplaying its role in the opioid epidemic, Purdue Pharma has embraced a federal statistic showing it was a minor player in the pain pill market. But when we took drug potency into account, Purdue’s importance soared.
by David Armstrong and Jeff Ernsthausen
View Story
[link removed]
[link removed]
Watch Richard Sackler Deny His Family’s Role in the Opioid Crisis
[link removed]
Sackler testified in 2015 in a lawsuit brought by Kentucky against his family’s company, Purdue Pharma, which makes the painkiller OxyContin. We published the transcript in February. Now you can see the video.
by David Armstrong
View Story
[link removed]
[link removed]
Sackler Embraced Plan to Conceal OxyContin’s Strength From Doctors, Sealed Testimony Shows
[link removed]
As OxyContin addiction spurred a national nightmare, a member of the family that has reaped billions of dollars from the painkiller boasted that sales exceeded his “fondest dreams,” according to a secret court document obtained by ProPublica.
by David Armstrong
View Story
[link removed]
[link removed]
OxyContin Maker Explored Expansion Into “Attractive” Anti-Addiction Market
[link removed]
Secret portions of a lawsuit allege that Purdue Pharma, controlled by the Sackler family, considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid.
by David Armstrong
View Story
[link removed]
A previous Big Story email misstated the names of two reporters. They are Lakeidra Chavis and Jennifer Smith Richards, not Lakeidra Davis and Jennifer Smith.
Support independent nonprofit news.
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
Was this email forwarded to you from a friend? Subscribe
[link removed]
.
This email was sent to
[email protected]. Update your email preferences
[link removed]
or unsubscribe
[link removed]
to stop receiving this newsletter. Email not displaying correctly? View it in your browser
[link removed]
.
ProPublica • 155 Ave of the Americas, 13th Floor • New York, NY 10013
